Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1689-6 ◽

2011 ◽

Vol 69 (1) ◽

pp. 215-220 ◽

Author(s):

Junshik Hong ◽

Minkyu Jung ◽

Yu Jin Kim ◽

Sun Jin Sym ◽

Sun Young Kyung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Extensive Disease ◽

Line Chemotherapy

Download Full-text

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

Journal of Translational Medicine ◽

10.1186/1479-5876-6-65 ◽

2008 ◽

Vol 6 (1) ◽

Author(s):

Alessandro Passardi ◽

Lorenzo Cecconetto ◽

Monia Dall'Agata ◽

Claudio Dazzi ◽

Enzo Pasquini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

Phase II study of gefitinib as first-line chemotherapy in patients with advanced non-small cell lung cancer harboring EGFR mutations and poor prognostic characteristics.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20625 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20625-e20625

Author(s):

Shuji Murakami ◽

Saki Manabe ◽

Tetsuro Kondo ◽

Haruhiro Saito ◽

Kouzo Yamada

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Egfr Mutations ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Weekly Regimen of Paclitaxel and Carboplatin as First-Line Chemotherapy in Elderly Patients with Stage IIIB-IV Non Small Cell Lung Cancer (NSCLC): Results of a Phase II Study

Journal of Chemotherapy ◽

10.1179/joc.2010.22.6.419 ◽

2010 ◽

Vol 22 (6) ◽

pp. 419-423 ◽

Author(s):

A. Rozzi ◽

C. Nardoni ◽

M. Corona ◽

M.R. Restuccia ◽

T. Falbo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0418-7 ◽

2007 ◽

Vol 60 (5) ◽

pp. 725-732 ◽

Author(s):

Joaquín Casal ◽

Margarita Amenedo ◽

José Ramón Mel ◽

Luis Miguel Antón ◽

Rubén Rodríguez-López ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Apatinib as maintenance therapy following standard first‐line chemotherapy in extensive disease small cell lung cancer: A phase II single‐arm trial

Thoracic Cancer ◽

10.1111/1759-7714.14298 ◽

2022 ◽

Author(s):

Fei Teng ◽

Puyuan Xing ◽

Ke Yang ◽

Lizhen Gao ◽

Zhongqiu Tian ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Extensive Disease ◽

Line Chemotherapy

Download Full-text

Customized First Line Chemotherapy According to ERCC1 and RRM1 SNPS in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients: A Phase II Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34208-3 ◽

2012 ◽

Vol 23 ◽

pp. ix528

Author(s):

F. Mazzoni ◽

G. Meoni ◽

F.L. Cecere ◽

C. Giuliani ◽

A. Camerini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Nsclc Patients ◽

Line Chemotherapy

Download Full-text

Preliminary results of a phase II study of irinotecan and etoposide combination as first line chemotherapy for extensive small-cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7366 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7366-7366 ◽

Author(s):

F. S. Farhat

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Preliminary Results ◽

Line Chemotherapy

Download Full-text

A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18023 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18023-e18023

Author(s):

L. Blakely ◽

L. S. Schwartzberg ◽

F. M. Schnell ◽

K. D. Sabbath ◽

P. J. Miller ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Line Chemotherapy

Download Full-text

Randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line chemotherapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7628 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7628-7628 ◽

Author(s):

S. Nagel ◽

A. Groeschel ◽

M. Sebastian ◽

S. Andreas ◽

T. Mueller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text